Adverse events and nursing diagnosis in patients undergoing hematopoietic stem cell transplantation
DOI:
https://doi.org/10.33448/rsd-v9i7.4618Keywords:
Hematopoietic stem cell transplantation; Nursing; Nursing process; Nursing diagnosis.Abstract
The aim of this study was to describe the adverse events presented by patients on the day of infusion of hematopoietic progenitor cells and to identify corresponding nursing diagnosis. Prospective cross-sectional study, whose sample consisted of 62 patients who underwent hematopoietic stem cell transplantation (allogeneic and autologous). After ethical approval, data collection took place over a period of 16 months in a public hospital in the state of São Paulo. About 53% of the transplant recipients were male, 54.8% had at least one comorbidity and 61.3% underwent allogeneic transplantation. For each type of adverse event (by organic system) presented, at least one nursing diagnosis was indicated, totaling 26 diagnosis and the most frequent ones were "risk of bleeding", "risk of allergic response", "fatigue" and "risk of impaired cardiovascular function". The highest frequency of elected nursing diagnosis belonged to the “security / protection” domain (n = 11), followed by the “activity / rest” domain (n = 5). This study found a higher frequency of nursing diagnosis belonging to the safety/protection domain and the activity/rest domain, which can be a reference for nurses in planning nursing care, with a view to the quality of care and the safety of onco-hematological patients.
References
Associação Brasileira de Transplante de Órgãos. (2019). Registro Brasileiro de Transplantes. Dimensionamento dos Transplantes no Brasil e em cada estado, 4, 1-95. Acesso em 15 maio, 2020, em http:// www.abto.org.br.
Brasil. Conselho Nacional de Saúde. (2012). Resolução n. 466, Normas Regulamentadoras de Pesquisas envolvendo seres humanos. Brasília: Ministério da Saúde.
Butcher, G.M., Bulechek H. K., Dochterman J.M., Wagner C.M. (2016). NIC Classificação das intervenções de Enfermagem. Rio de Janeiro: Gen Guanabara Koogan.
Canaani, J., Savani, B. N., Labopin, M., Huang, X. J., Ciceri, F., Arcese, W., . . . Nagler, A. (2018). Donor age determines outcome in acute leukemia patients over 40 undergoing haploidentical hematopoietic cell transplantation. Am J Hematol, 93(2), 246-253. doi:10.1002/ajh.24963
Colella, M.P., Miranda, E.C.M., Aranha, F.J.P., Vigorito, A.C. & De Souza CA. (2014).
Hematopoietic cell transplant specific comorbidity index, disease status at transplant and graft source as risk factors in patients undergoing allogeneic hematopoietic stem cell transplant. Journal of Hematology & Transfusion, 2(3), 1031-7.
Ezzone, A.S. (2009). History of hematopoietic stem cell transplantation. Seminars in Oncology Nursing, 25, 95-9.
Hening, I. & Zuckerman, T. (2014). Hematopoietic stem cell transplantation-50 years of evolution and future perpectives. Rambam Maimonides Med J, 5(4), 1-15.
Keller, J. W., Andreadis, C., Damon, L. E., Kaplan, L. D., Martin, T. G., Wolf, J. L., . . . Olin, R. L. (2014). Hematopoietic cell transplantation comorbidity index (HCT-CI) is predictive of adverse events and overall survival in older allogeneic transplant recipients. J Geriatr Oncol, 5(3), 238-244. doi:10.1016/j.jgo.2014.04.003
Larghero, J., Rea, D., Esperou, H., Biscay, N., Maurer, M. N., Lacassagne, M. N., . . . Marolleau, J. P. (2006). ABO-mismatched marrow processing for transplantation: results of 114 procedures and analysis of immediate adverse events and hematopoietic recovery. Transfusion, 46(3), 398-402. doi:10.1111/j.1537-2995.2006.00735.x
National Cancer Institute. (2010). Common Terminology Criteria for Adverse Events (version 4.0). Acesso em 15 maio, 2020, em https://evs.nci.nih.gov/ftp1/CTCAE/CTCAE_ 4.03/CTCAE_4.03_2010-06 14_QuickReference_8.5x11.pdf
North American Nursing Diagnosis Association – International. (2015-2017). Diagnósticos de Enfermagem da NANDA-I: definições e classificação. Porto Alegre: Artmed.
Sauer-Heilborn, A., Kadidlo, D., & McCullough, J. (2004). Patient care during infusion of hematopoietic progenitor cells. Transfusion, 44(6), 907-916. doi:10.1111/j.1537-2995.2004.03230.x
Shu, Z., Heimfeld, S., & Gao, D. (2014). Hematopoietic SCT with cryopreserved grafts: adverse reactions after transplantation and cryoprotectant removal before infusion. Bone Marrow Transplant, 49(4), 469-476. doi:10.1038/bmt.2013.152
Silva, J. B., Póvoa, V. C., Lima, M. H., Oliveira, H. C., Padilha, K. G., & Secoli, S. R. (2015). Nursing workload in hematopoietic stem cell transplantation: a cohort study. Rev Esc Enferm USP, 49 Spec No, 93-100. doi:10.1590/S0080-623420150000700014
Sorror, M. L. (2010). Comorbidities and hematopoietic cell transplantation outcomes. Hematology Am Soc Hematol Educ Program, 2010, 237-247. doi:10.1182/asheducation-2010.1.237
Sousa, R.M., Santo, F.H.E., Santana, R.F. & Lopes, M.V.O. (2015). Diagnósticos de
enfermagem identificados em pacientes onco-hematológicos: mapeamento cruzado.
Escola Anna Nery Revista de Enfermagem, 19(1), 54-65.
Timurağaoğlu, A. (2015). The role of the nurses and technicians for stem cell mobilisation and collection. Transfus Apher Sci, 53(1), 30-33. doi:10.1016/j.transci.2015.05.012
Ubaldo, I., Matos, E. & Salum, N.C. (2015). Diagnósticos de enfermagem da NANDA-I
com base nos problemas segundo teoria de Wanda Horta. Cogitare Enferm, 20(4), 687-94.
Vidula, N., Villa, M., Helenowski, I. B., Merchant, M., Jovanovic, B. D., Meagher, R., . . . Gordon, L. I. (2015). Adverse Events During Hematopoietic Stem Cell Infusion: Analysis of the Infusion Product. Clin Lymphoma Myeloma Leuk, 15(11), e157-162. doi:10.1016/j.clml.2015.08.085
Worldwide Network for Blood and Marrow Transplantation. (2013). Acesso em 15 maio, 2020, em http://www.wbmt.org.
Downloads
Published
How to Cite
Issue
Section
License
Authors who publish with this journal agree to the following terms:
1) Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
2) Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
3) Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.